Peptides for Dogs: What the Research Actually Shows
By Chad Singer, founder of Canine Revolution Dog Training · Citadel Alumni · Navy veteran · 1,000+ dogs trained since 2017 · Last reviewed: October 2026
Peptides like BPC-157, SS-31, and TB-500 are being sold online as healing and anti-aging shots for dogs. We went through the published research behind every peptide in our video to separate what has been shown in dogs from what is borrowed from rats, mice, and people. Each answer below says what the evidence shows and links to the source.
Read this first: I’m a dog trainer, not a veterinarian, and this page is not medical advice or a dosing guide. Don’t start any peptide without your veterinarian and baseline bloodwork.
The evidence at a glance
| Peptide | What it’s sold for | Best evidence | Tested in dogs? |
|---|---|---|---|
| SS-31 (elamipretide) | Heart, mitochondria, aging | Lab dogs with induced heart failure; approved for a rare human disease | Yes, lab dogs only |
| BPC-157 | Tendons, ligaments, gut | Rats and cell studies | Lab beagles: safety and dosing only |
| TB-500 | Tissue repair | Rodents | None found |
| CJC-1295, ipamorelin, GHRP-6, tesamorelin | Muscle, anti-aging | People, pigs, rats | Hormone response and toxicity in lab dogs only |
| MOTS-c | Metabolism, weight | Mice | None found |
| Epitalon | Sleep, aging | Monkeys | None found |
| Thymosin alpha-1 | Immune support | People | None found |
| GHK-Cu | Wound healing | Rats, rabbits, one small dog study | One study of 12 dogs (paw-pad wounds) |
| GLP-1 drugs (Ozempic, Wegovy) | Weight loss | Approved human drugs; first cat trial began in 2025 | Poisoning reports only |
The basics
What is a peptide?
A peptide is a short chain of amino acids, usually 2 to 50, linked together. Proteins are long chains; peptides are short ones. Many peptides work as signals: they bind to receptors on cells and switch processes on or off, such as inflammation, blood vessel growth, or hormone release.
Sources:
- Peptide — National Human Genome Research Institute, Talking Glossary. Defines a peptide as a short chain of amino acids, typically 2 to 50, linked by peptide bonds. https://www.genome.gov/genetics-glossary/Peptide
- Therapeutic peptides: current applications and future directions — Wang L et al., Signal Transduction and Targeted Therapy (2022). Review of how peptide drugs work and how they are developed and delivered. https://pmc.ncbi.nlm.nih.gov/articles/PMC8844085/
Are peptides for dogs proven to work?
Mostly, no. We looked for a published clinical trial in pet dogs for every peptide in our video and did not find one. The dog research that does exist is lab work: safety and dosing studies in lab beagles, and one heart study in dogs whose heart failure was created in a lab. Most of what you read online is borrowed from rat, mouse, cell, or human research.
Sources:
- Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157 in rats and dogs — He L et al., Frontiers in Pharmacology (2022). Lab study in beagles given BPC-157 by IV or intramuscular injection; it was cleared in under 30 minutes and well tolerated. Oral use and effectiveness were not tested. https://pmc.ncbi.nlm.nih.gov/articles/PMC9794587/
- Preclinical safety evaluation of body protective compound-157 — Xu C et al., Regulatory Toxicology and Pharmacology (2020). Safety study in mice, rats, rabbits, and dogs that found no serious toxicity; it did not test whether BPC-157 works. https://pubmed.ncbi.nlm.nih.gov/32334036/
- Mitochondrial therapy with elamipretide (MTP-131) improves mitochondrial function and left ventricular function in dogs with advanced heart failure — Sabbah HN et al., Circulation: Heart Failure (2016). In 14 dogs with heart failure induced in a lab, 3 months of daily SS-31 raised ejection fraction from about 30% to 36% while untreated dogs declined; funded by the drug’s maker. https://pmc.ncbi.nlm.nih.gov/articles/PMC4743543
Can peptides for dogs be given by mouth?
Most can’t reach the bloodstream that way. Digestive enzymes break peptides down, which is why most peptide drugs are injected, and oral versions need special technology to get through the gut.
BPC-157 is the one people point to as working orally. In rats, BPC-157 in drinking water healed surgically created gut injuries. That effect was on the gut itself, in rats. No one has published a study of oral BPC-157 in dogs.
Sources:
- Advances in oral peptide therapeutics — Drucker DJ, Nature Reviews Drug Discovery (2020). Peptide drugs normally have to be injected because the digestive tract is a major barrier; oral versions need special technology to get through. https://pubmed.ncbi.nlm.nih.gov/31848464/
- Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula — Grgic T et al., European Journal of Pharmacology (2016). BPC-157 given in drinking water or by injection healed surgically created colon-to-bladder fistulas in rats. https://pubmed.ncbi.nlm.nih.gov/26875638/
Are these peptides approved drugs?
A few are approved for people. The FDA gave elamipretide (SS-31) accelerated approval for Barth syndrome, a rare human disease, in 2025, and semaglutide is the human weight-loss and diabetes drug sold as Ozempic and Wegovy. The others in our video, including BPC-157 and TB-500, are not approved drugs. The FDA has flagged safety concerns about compounding many of them, and they are mostly sold online as “research chemicals.”
Sources:
- FDA grants accelerated approval to first treatment for Barth syndrome — U.S. Food and Drug Administration (September 19, 2025). Elamipretide (Forzinity) received accelerated approval for Barth syndrome, a rare human disease; a confirmatory trial is still required. https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-treatment-barth-syndrome
- Safety risks associated with certain bulk drug substances nominated for use in compounding — U.S. Food and Drug Administration. Lists ipamorelin and GHRP-6 as having significant safety risks for compounding, and notes immunogenicity risks and limited or no safety data for BPC-157, TB-500, CJC-1295, MOTS-c, epitalon, thymosin alpha-1, and GHK-Cu. https://www.fda.gov/drugs/human-drug-compounding/safety-risks-associated-certain-bulk-drug-substances-nominated-use-compounding
The evidence, peptide by peptide
What does the research say about BPC-157 for dogs?
BPC-157 gets the most hype and has very little dog evidence. In rats, injected BPC-157 helped surgically cut Achilles tendons heal faster and stronger. In dogs, the only published work is two lab studies in beagles. One measured how it moves through the body after injection and found it is cleared in under 30 minutes. The other was a safety study that found no serious toxicity. Neither tested whether it helps anything heal.
Sources:
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth — Staresinic M et al., Journal of Orthopaedic Research (2003). Rats with surgically cut Achilles tendons healed faster and stronger on injected BPC-157. https://pubmed.ncbi.nlm.nih.gov/14554208/
- Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157 in rats and dogs — He L et al., Frontiers in Pharmacology (2022). Lab study in beagles given BPC-157 by IV or intramuscular injection; it was cleared in under 30 minutes and well tolerated. Oral use and effectiveness were not tested. https://pmc.ncbi.nlm.nih.gov/articles/PMC9794587/
- Preclinical safety evaluation of body protective compound-157 — Xu C et al., Regulatory Toxicology and Pharmacology (2020). Safety study in mice, rats, rabbits, and dogs that found no serious toxicity; it did not test whether BPC-157 works. https://pubmed.ncbi.nlm.nih.gov/32334036/
Can BPC-157 heal a torn CCL in a dog?
There is no evidence that it can. No study has tested BPC-157 on a torn CCL, arthritis, hip dysplasia, or IBD in dogs. The closest evidence is rats with cut Achilles tendons. If your dog has a ligament injury, get a diagnosis from your vet before trying anything that could delay treatment.
Sources:
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth — Staresinic M et al., Journal of Orthopaedic Research (2003). Rats with surgically cut Achilles tendons healed faster and stronger on injected BPC-157. https://pubmed.ncbi.nlm.nih.gov/14554208/
- Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157 in rats and dogs — He L et al., Frontiers in Pharmacology (2022). Lab study in beagles given BPC-157 by IV or intramuscular injection; it was cleared in under 30 minutes and well tolerated. Oral use and effectiveness were not tested. https://pmc.ncbi.nlm.nih.gov/articles/PMC9794587/
Is BPC-157 safe for dogs with cancer?
No one has tested it, and there is a reason for caution. In lab studies, BPC-157 drives new blood vessel growth by activating a receptor called VEGFR2. Tumors also rely on new blood vessels to grow. That makes cancer a theoretical concern, not a proven one, so talk to your vet first if your dog has cancer, a history of cancer, or a suspected tumor.
Sources:
- Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation — Hsieh MJ et al., Journal of Molecular Medicine (2017). In chick embryos, rats, and human cells, BPC-157 increased new blood vessel growth by activating the VEGFR2 receptor. https://pubmed.ncbi.nlm.nih.gov/27847966/
What is TB-500, and does it work for dogs?
TB-500 is a synthetic piece of a natural protein called thymosin beta-4. In rodents, thymosin beta-4 boosted blood vessel growth and wound repair. We found no studies of TB-500 in dogs. It is banned in horse racing and other sports, and racing labs have built tests to catch it. Like BPC-157, it promotes blood vessel growth, so the same cancer caution applies.
Sources:
- Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development — Philp D et al., Mechanisms of Ageing and Development (2004). In rodents, thymosin beta-4 increased blood vessel growth, wound repair, and hair growth. https://pubmed.ncbi.nlm.nih.gov/15037013/
- Equine doping controls of thymosin β4: a population study and strategy for misuse detection — Delcourt V et al., Drug Testing and Analysis (2025). Notes that thymosin beta-4 is prohibited by international horse racing (IFHA), equestrian (FEI), and anti-doping (WADA) authorities. https://pubmed.ncbi.nlm.nih.gov/39314109/
- Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma — Ho EN et al., Journal of Chromatography A (2012). The Hong Kong Jockey Club racing lab built a test to detect TB-500 misuse in horses. https://pubmed.ncbi.nlm.nih.gov/23084823/
Does SS-31 (elamipretide) help dogs with heart disease?
SS-31 has the most meaningful dog data of any peptide in our video, with real limits. In a 2016 study, 7 dogs with heart failure created in a lab got SS-31 daily for 3 months. Their ejection fraction, a measure of how well the heart pumps, rose from about 30% to 36%, while untreated dogs declined. Their heart cells’ mitochondria also worked better.
The limits: these dogs started near 50% before their heart failure was induced, so the improvement was partial. The study was small, it was funded by the drug’s maker, and it was not done in pet dogs or in dogs with DCM. If your dog has heart disease, this is a study to bring to a veterinary cardiologist, not a reason to order a vial online.
Sources:
- Mitochondrial therapy with elamipretide (MTP-131) improves mitochondrial function and left ventricular function in dogs with advanced heart failure — Sabbah HN et al., Circulation: Heart Failure (2016). In 14 dogs with heart failure induced in a lab, 3 months of daily SS-31 raised ejection fraction from about 30% to 36% while untreated dogs declined; funded by the drug’s maker. https://pmc.ncbi.nlm.nih.gov/articles/PMC4743543
- FDA grants accelerated approval to first treatment for Barth syndrome — U.S. Food and Drug Administration (September 19, 2025). Elamipretide (Forzinity) received accelerated approval for Barth syndrome, a rare human disease; a confirmatory trial is still required. https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-treatment-barth-syndrome
Does SS-31 protect a dog's joints?
It hasn’t been tested in dogs. A Cornell lab study used cow knee cartilage in a dish: SS-31 given within 12 hours of an impact injury kept the cartilage cells alive. That’s an early lab finding, not a treatment for arthritis in living animals.
Sources:
- Mitoprotective therapy preserves chondrocyte viability and prevents cartilage degeneration in an ex vivo model of posttraumatic osteoarthritis — Delco ML et al., Journal of Orthopaedic Research (2018). Cornell lab study on cow knee cartilage: SS-31 given within 12 hours of an impact injury kept cartilage cells alive for up to 7 days. https://pubmed.ncbi.nlm.nih.gov/29469223/
Do growth hormone peptides help senior dogs build muscle?
We found no evidence that they do. CJC-1295, ipamorelin, GHRP-6, and tesamorelin all push the body to release more growth hormone. In lab beagles, GHRP-6 raised growth hormone without significantly raising cortisol. Ipamorelin was tested in rats and pigs, and CJC-1295 in people. No study shows any of them builds muscle or improves mobility in older dogs.
There are real warning signs. In a year-long lab study, dogs given tesamorelin developed signs of growth hormone excess, insulin resistance or diabetes, and antibodies to the drug. The FDA lists ipamorelin and GHRP-6 as having significant safety risks, citing serious adverse events in people.
Sources:
- Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism — Bhatti SF et al., Molecular and Cellular Endocrinology (2002). GHRP-6 raised growth hormone in dogs without significantly raising ACTH or cortisol. https://pubmed.ncbi.nlm.nih.gov/12431802/
- Effects of growth hormone secretagogues on the release of adenohypophyseal hormones in young and old healthy dogs — Bhatti SF et al., The Veterinary Journal (2006). In beagles, GHRP-6 and related compounds raised growth hormone without significantly raising ACTH or cortisol. https://pubmed.ncbi.nlm.nih.gov/15951209/
- Ipamorelin, the first selective growth hormone secretagogue — Raun K et al., European Journal of Endocrinology (1998). Tested in rats and pigs; ipamorelin released growth hormone without raising ACTH or cortisol. No dogs were studied. https://pubmed.ncbi.nlm.nih.gov/9849822/
- Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295 in healthy adults — Teichman SL et al., Journal of Clinical Endocrinology & Metabolism (2006). A human study: one CJC-1295 injection raised growth hormone and IGF-1 for days. No dog data were found. https://pubmed.ncbi.nlm.nih.gov/16352683/
- Withdrawal assessment report: Egrifta (tesamorelin) — European Medicines Agency. In a 52-week lab study, dogs given tesamorelin developed signs of growth hormone excess (acromegaly), insulin resistance or diabetes, and antibodies to the drug. https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-egrifta_en.pdf
- Safety risks associated with certain bulk drug substances nominated for use in compounding — U.S. Food and Drug Administration. Lists ipamorelin and GHRP-6 as having significant safety risks for compounding, and notes immunogenicity risks and limited or no safety data for BPC-157, TB-500, CJC-1295, MOTS-c, epitalon, thymosin alpha-1, and GHK-Cu. https://www.fda.gov/drugs/human-drug-compounding/safety-risks-associated-certain-bulk-drug-substances-nominated-use-compounding
Is there evidence for MOTS-c, Epitalon, or thymosin alpha-1 in dogs?
No. MOTS-c prevented diet-induced obesity and insulin resistance in mice. Epitalon raised evening melatonin in a small study of old monkeys, run by the institute that developed it. Thymosin alpha-1 is an immune peptide studied in people. We found no published dog studies for any of the three, including for Lyme disease. The FDA notes little or no safety data for them even in humans.
Sources:
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance — Lee C et al., Cell Metabolism (2015). In mice, MOTS-c prevented diet-induced obesity and insulin resistance. No dog studies were found. https://pubmed.ncbi.nlm.nih.gov/25738459/
- Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys — Khavinson V et al., Neuroendocrinology Letters (2001). A small study in old rhesus monkeys from the developer’s own institute: epitalon raised evening melatonin. No dog studies were found. https://pubmed.ncbi.nlm.nih.gov/11524632/
- Thymosin alpha 1: isolation and sequence analysis of an immunologically active thymic polypeptide — Goldstein AL et al., Proceedings of the National Academy of Sciences (1977). The paper that first isolated and identified thymosin alpha-1, an immune peptide, from calf thymus. No canine clinical studies were found. https://pubmed.ncbi.nlm.nih.gov/265536/
- Safety risks associated with certain bulk drug substances nominated for use in compounding — U.S. Food and Drug Administration. Lists ipamorelin and GHRP-6 as having significant safety risks for compounding, and notes immunogenicity risks and limited or no safety data for BPC-157, TB-500, CJC-1295, MOTS-c, epitalon, thymosin alpha-1, and GHK-Cu. https://www.fda.gov/drugs/human-drug-compounding/safety-risks-associated-certain-bulk-drug-substances-nominated-use-compounding
Is GHK-Cu safe for dogs?
GHK-Cu, a copper peptide, has a little animal evidence for wound healing. In one study of 12 dogs, paw-pad wounds injected with a copper-peptide complex had more new collagen at 14 days, and wounds in rabbits healed faster.
Copper is the concern. Bedlington Terriers, Labrador Retrievers, and Doberman Pinschers, along with Westies, Skye Terriers, Keeshonds, and American Cocker Spaniels, can inherit a tendency to build up copper in the liver. Talk to your vet before using any copper product on these breeds, including on the skin, since dogs lick.
Sources:
- The human tri-peptide GHK and tissue remodeling — Pickart L, Journal of Biomaterials Science, Polymer Edition (2008). Review reporting that GHK-Cu stimulates collagen production and wound healing in lab models and in people. https://pubmed.ncbi.nlm.nih.gov/18644225/
- Effect of locally injected medications on healing of pad wounds in dogs — Swaim SF et al., American Journal of Veterinary Research (1996). In 12 dogs, paw-pad wounds injected with a tripeptide-copper complex had more new collagen at 14 days. https://pubmed.ncbi.nlm.nih.gov/8669775/
- Effects of cod liver oil and tripeptide-copper complex on healing of skin wounds in rabbits — Cangul IT et al., Veterinary Dermatology (2006). In rabbits, wounds treated with a tripeptide-copper complex were smaller than untreated wounds at 7, 14, and 21 days. https://pubmed.ncbi.nlm.nih.gov/17083573/
- Copper Toxicosis in Animals — Merck Veterinary Manual. Bedlington Terriers, Labrador Retrievers, and Doberman Pinschers, among other breeds, have documented inherited copper buildup in the liver. https://www.merckvetmanual.com/toxicology/copper-toxicosis/copper-toxicosis-in-animals
- The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers — Fieten H et al., Disease Models & Mechanisms (2016). In 235 Labradors, a gene variant was linked to copper buildup in the liver. https://pmc.ncbi.nlm.nih.gov/articles/PMC4728329/
Ozempic and GLP-1 drugs
Is Ozempic safe for dogs?
Never give a dog a human GLP-1 drug like Ozempic, Wegovy, or Mounjaro at home. GLP-1 research in pets is real, but it is early: the first clinical trial testing a GLP-1 drug for weight loss in cats began in late 2025, and the company plans to study dogs later.
Sources:
- Can GLP-1s help fat cats lose weight? The first clinical trial testing the drugs for weight loss in felines has begun — Smithsonian Magazine (December 2025). Okava Pharmaceuticals began a trial of a 6-month GLP-1 implant in at least 50 cats, the first test of the drugs for weight loss in cats. https://www.smithsonianmag.com/smart-news/can-glp-1s-help-fat-cats-lose-weight-the-first-clinical-trial-testing-the-drugs-for-weight-loss-in-felines-has-begun-180987833/
- Weight-loss drugs for cats? Company launches clinical trial of GLP-1 implants — ABC13 (December 2025). Reports the company plans to study dogs after cats, with no timeline. https://abc13.com/post/weight-loss-drugs-cats-company-launches-clinical-trial-glp-1-implants/18245988/
What happens if a dog eats or chews an Ozempic pen?
The most common signs are vomiting, diarrhea, lethargy, and decreased appetite. Low blood sugar and pancreatitis are less likely but possible. The most serious cases Pet Poison Helpline has seen were diabetic pets accidentally injected with a GLP-1 pen, which looks like an insulin pen. Those pets developed severe low blood sugar and needed hospital care. Store GLP-1 pens away from your pet’s insulin and out of chewing reach.
If your dog gets into one, call your vet or a pet poison hotline: ASPCA Animal Poison Control (888) 426-4435 or Pet Poison Helpline (855) 764-7661. Fees may apply.
Sources:
- Pet Safety Alert: Rising GLP-1 Pet Exposures — ASPCA Animal Poison Control (March 2026). Most common signs after exposure are vomiting, diarrhea, lethargy, and decreased appetite; low blood sugar and pancreatitis are unlikely but possible. https://www.aspca.org/news/pet-safety-alert-rising-glp-1-pet-exposures
- Are Pets Being Poisoned with Ozempic? — Pet Poison Helpline. GLP-1 pens look like insulin pens; diabetic pets accidentally injected with them developed severe low blood sugar and needed hospital care. https://www.petpoisonhelpline.com/toxintails/are-pets-being-poisoned-with-ozempic
Doing it responsibly
Are "research chemical" peptides sold online safe for dogs?
You can’t know what’s in the vial. In 2026 warning letters to online peptide sellers, the FDA said “research use only” labels don’t change the fact that the products are unapproved drugs. When researchers bought semaglutide online without a prescription, the vials were only 7.7% to 14.4% pure against 99% claimed, all contained bacterial endotoxin, and the pens they ordered never arrived. No one has published quality testing of online BPC-157.
Sources:
- Warning letter: Peak Performance Peptides — U.S. Food and Drug Administration (August 2026). FDA found that peptides labeled “research use only” were in fact sold as unapproved drugs for human use. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peak-performance-peptides-735127-08242026
- Warning letter: Pink Pony Peptides — U.S. Food and Drug Administration (March 2026). FDA warned that injectable products bypass some of the body’s key defenses against toxins and microorganisms. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovega-llc-dba-pink-pony-peptides-721088-03312026
- Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription — Ashraf AR et al., Journal of Medical Internet Research (2024). Semaglutide vials bought online were 7.7% to 14.4% pure against 99% claimed, all contained bacterial endotoxin, and the ordered pens never arrived. https://pmc.ncbi.nlm.nih.gov/articles/PMC11582493/
What bloodwork should my dog have before trying something experimental?
Start with a baseline. AAHA guidelines recommend bloodwork and a urinalysis for young adult dogs, yearly for mature adults, and every 6 to 12 months for seniors. If you and your vet decide to try anything experimental, get labs before you start and repeat them during, so you can see changes in liver values, kidney values, and blood sugar.
Sources:
- 2019 AAHA Canine Life Stage Guidelines: Diagnostic testing for each life stage — American Animal Hospital Association. Recommends baseline bloodwork and urinalysis in young adult dogs, yearly testing in mature adults, and every 6 to 12 months in seniors. https://www.aaha.org/resources/life-stage-canine-2019/diagnostic-testing-for-each-life-stage/
How do I talk to my vet about peptides?
Lead with the problem, not the product. Say, “My dog’s arthritis isn’t well controlled on his current plan and his mobility is getting worse. What else can we try?” Then ask what the evidence says about any option you’ve read about. If your vet isn’t familiar with it, ask for a referral to a veterinary internist, cardiologist, or rehabilitation specialist. The AHVMA also keeps a directory of licensed vets who offer integrative care.
Sources:
- VetFinder: Find a Holistic Veterinarian — American Holistic Veterinary Medical Association. Directory of U.S. licensed veterinarians who offer integrative and holistic services. https://www.ahvma.org/find-a-holistic-veterinarian/
What should I fix before considering peptides for my dog?
The foundations: body weight, nutrition, exercise, and training. In a lifetime study of 48 paired Labradors, dogs fed 25% less lived a median of about 13 years versus 11.2 and developed chronic disease later. In our experience, a dog that lunges and pulls on the leash every day is also putting real strain on its joints, and no peptide fixes that. Build the foundation first.
Sources:
- Effects of diet restriction on life span and age-related changes in dogs — Kealy RD et al., Journal of the American Veterinary Medical Association (2002). In 48 paired Labradors, dogs fed 25% less lived significantly longer and developed chronic disease later. https://pubmed.ncbi.nlm.nih.gov/11991408/
- Study finds dogs fed reduced-calorie diet live nearly two years longer — Penn Today, University of Pennsylvania (2002). Reports the Labrador study’s median life spans: 13 years for lean-fed dogs versus 11.2 years for the comparison group. https://penntoday.upenn.edu/news/study-finds-dogs-fed-reduced-calorie-diet-live-nearly-two-years-longer-dogs-unrestricted-diet
How should I evaluate any peptide or supplement claim?
Run it through four questions. One: what published, dog-specific evidence exists? Two: is the claim based on real dogs, or borrowed from mice, rats, or people? Three: what problem am I solving, and have I already handled weight, nutrition, exercise, training, and standard vet care? Four: will I do this the responsible way, with a vet, a legitimate source, and regular bloodwork?
Source: Canine Revolution’s approach, from Chad Singer’s video and Pack Talk Podcast.
How we researched this
We checked every claim in our video against the published research: studies on PubMed, documents from the FDA and the European Medicines Agency, veterinary references like the Merck Veterinary Manual and AAHA, and pet poison-control centers. We opened each study ourselves instead of relying on summaries. Where a claim from the video didn’t hold up, this page follows the research. We left out supplement sellers and peptide vendors, and we don’t give doses or protocols.
Full source list
- Peptide — National Human Genome Research Institute, Talking Glossary. Defines a peptide as a short chain of amino acids, typically 2 to 50, linked by peptide bonds. https://www.genome.gov/genetics-glossary/Peptide
- Therapeutic peptides: current applications and future directions — Wang L et al., Signal Transduction and Targeted Therapy (2022). Review of how peptide drugs work and how they are developed and delivered. https://pmc.ncbi.nlm.nih.gov/articles/PMC8844085/
- Advances in oral peptide therapeutics — Drucker DJ, Nature Reviews Drug Discovery (2020). Peptide drugs normally have to be injected because the digestive tract is a major barrier; oral versions need special technology to get through. https://pubmed.ncbi.nlm.nih.gov/31848464/
- Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157 in rats and dogs — He L et al., Frontiers in Pharmacology (2022). Lab study in beagles given BPC-157 by IV or intramuscular injection; it was cleared in under 30 minutes and well tolerated. Oral use and effectiveness were not tested. https://pmc.ncbi.nlm.nih.gov/articles/PMC9794587/
- Preclinical safety evaluation of body protective compound-157 — Xu C et al., Regulatory Toxicology and Pharmacology (2020). Safety study in mice, rats, rabbits, and dogs that found no serious toxicity; it did not test whether BPC-157 works. https://pubmed.ncbi.nlm.nih.gov/32334036/
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth — Staresinic M et al., Journal of Orthopaedic Research (2003). Rats with surgically cut Achilles tendons healed faster and stronger on injected BPC-157. https://pubmed.ncbi.nlm.nih.gov/14554208/
- Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula — Grgic T et al., European Journal of Pharmacology (2016). BPC-157 given in drinking water or by injection healed surgically created colon-to-bladder fistulas in rats. https://pubmed.ncbi.nlm.nih.gov/26875638/
- Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation — Hsieh MJ et al., Journal of Molecular Medicine (2017). In chick embryos, rats, and human cells, BPC-157 increased new blood vessel growth by activating the VEGFR2 receptor. https://pubmed.ncbi.nlm.nih.gov/27847966/
- Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development — Philp D et al., Mechanisms of Ageing and Development (2004). In rodents, thymosin beta-4 increased blood vessel growth, wound repair, and hair growth. https://pubmed.ncbi.nlm.nih.gov/15037013/
- Equine doping controls of thymosin β4: a population study and strategy for misuse detection — Delcourt V et al., Drug Testing and Analysis (2025). Notes that thymosin beta-4 is prohibited by international horse racing (IFHA), equestrian (FEI), and anti-doping (WADA) authorities. https://pubmed.ncbi.nlm.nih.gov/39314109/
- Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma — Ho EN et al., Journal of Chromatography A (2012). The Hong Kong Jockey Club racing lab built a test to detect TB-500 misuse in horses. https://pubmed.ncbi.nlm.nih.gov/23084823/
- Mitochondrial therapy with elamipretide (MTP-131) improves mitochondrial function and left ventricular function in dogs with advanced heart failure — Sabbah HN et al., Circulation: Heart Failure (2016). In 14 dogs with heart failure induced in a lab, 3 months of daily SS-31 raised ejection fraction from about 30% to 36% while untreated dogs declined; funded by the drug’s maker. https://pmc.ncbi.nlm.nih.gov/articles/PMC4743543
- FDA grants accelerated approval to first treatment for Barth syndrome — U.S. Food and Drug Administration (September 19, 2025). Elamipretide (Forzinity) received accelerated approval for Barth syndrome, a rare human disease; a confirmatory trial is still required. https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-treatment-barth-syndrome
- Mitoprotective therapy preserves chondrocyte viability and prevents cartilage degeneration in an ex vivo model of posttraumatic osteoarthritis — Delco ML et al., Journal of Orthopaedic Research (2018). Cornell lab study on cow knee cartilage: SS-31 given within 12 hours of an impact injury kept cartilage cells alive for up to 7 days. https://pubmed.ncbi.nlm.nih.gov/29469223/
- Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism — Bhatti SF et al., Molecular and Cellular Endocrinology (2002). GHRP-6 raised growth hormone in dogs without significantly raising ACTH or cortisol. https://pubmed.ncbi.nlm.nih.gov/12431802/
- Effects of growth hormone secretagogues on the release of adenohypophyseal hormones in young and old healthy dogs — Bhatti SF et al., The Veterinary Journal (2006). In beagles, GHRP-6 and related compounds raised growth hormone without significantly raising ACTH or cortisol. https://pubmed.ncbi.nlm.nih.gov/15951209/
- Ipamorelin, the first selective growth hormone secretagogue — Raun K et al., European Journal of Endocrinology (1998). Tested in rats and pigs; ipamorelin released growth hormone without raising ACTH or cortisol. No dogs were studied. https://pubmed.ncbi.nlm.nih.gov/9849822/
- Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295 in healthy adults — Teichman SL et al., Journal of Clinical Endocrinology & Metabolism (2006). A human study: one CJC-1295 injection raised growth hormone and IGF-1 for days. No dog data were found. https://pubmed.ncbi.nlm.nih.gov/16352683/
- Withdrawal assessment report: Egrifta (tesamorelin) — European Medicines Agency. In a 52-week lab study, dogs given tesamorelin developed signs of growth hormone excess (acromegaly), insulin resistance or diabetes, and antibodies to the drug. https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-egrifta_en.pdf
- Safety risks associated with certain bulk drug substances nominated for use in compounding — U.S. Food and Drug Administration. Lists ipamorelin and GHRP-6 as having significant safety risks for compounding, and notes immunogenicity risks and limited or no safety data for BPC-157, TB-500, CJC-1295, MOTS-c, epitalon, thymosin alpha-1, and GHK-Cu. https://www.fda.gov/drugs/human-drug-compounding/safety-risks-associated-certain-bulk-drug-substances-nominated-use-compounding
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance — Lee C et al., Cell Metabolism (2015). In mice, MOTS-c prevented diet-induced obesity and insulin resistance. No dog studies were found. https://pubmed.ncbi.nlm.nih.gov/25738459/
- Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys — Khavinson V et al., Neuroendocrinology Letters (2001). A small study in old rhesus monkeys from the developer’s own institute: epitalon raised evening melatonin. No dog studies were found. https://pubmed.ncbi.nlm.nih.gov/11524632/
- Thymosin alpha 1: isolation and sequence analysis of an immunologically active thymic polypeptide — Goldstein AL et al., Proceedings of the National Academy of Sciences (1977). The paper that first isolated and identified thymosin alpha-1, an immune peptide, from calf thymus. No canine clinical studies were found. https://pubmed.ncbi.nlm.nih.gov/265536/
- The human tri-peptide GHK and tissue remodeling — Pickart L, Journal of Biomaterials Science, Polymer Edition (2008). Review reporting that GHK-Cu stimulates collagen production and wound healing in lab models and in people. https://pubmed.ncbi.nlm.nih.gov/18644225/
- Effect of locally injected medications on healing of pad wounds in dogs — Swaim SF et al., American Journal of Veterinary Research (1996). In 12 dogs, paw-pad wounds injected with a tripeptide-copper complex had more new collagen at 14 days. https://pubmed.ncbi.nlm.nih.gov/8669775/
- Effects of cod liver oil and tripeptide-copper complex on healing of skin wounds in rabbits — Cangul IT et al., Veterinary Dermatology (2006). In rabbits, wounds treated with a tripeptide-copper complex were smaller than untreated wounds at 7, 14, and 21 days. https://pubmed.ncbi.nlm.nih.gov/17083573/
- Copper Toxicosis in Animals — Merck Veterinary Manual. Bedlington Terriers, Labrador Retrievers, and Doberman Pinschers, among other breeds, have documented inherited copper buildup in the liver. https://www.merckvetmanual.com/toxicology/copper-toxicosis/copper-toxicosis-in-animals
- The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers — Fieten H et al., Disease Models & Mechanisms (2016). In 235 Labradors, a gene variant was linked to copper buildup in the liver. https://pmc.ncbi.nlm.nih.gov/articles/PMC4728329/
- Pet Safety Alert: Rising GLP-1 Pet Exposures — ASPCA Animal Poison Control (March 2026). Most common signs after exposure are vomiting, diarrhea, lethargy, and decreased appetite; low blood sugar and pancreatitis are unlikely but possible. https://www.aspca.org/news/pet-safety-alert-rising-glp-1-pet-exposures
- Are Pets Being Poisoned with Ozempic? — Pet Poison Helpline. GLP-1 pens look like insulin pens; diabetic pets accidentally injected with them developed severe low blood sugar and needed hospital care. https://www.petpoisonhelpline.com/toxintails/are-pets-being-poisoned-with-ozempic
- Can GLP-1s help fat cats lose weight? The first clinical trial testing the drugs for weight loss in felines has begun — Smithsonian Magazine (December 2025). Okava Pharmaceuticals began a trial of a 6-month GLP-1 implant in at least 50 cats, the first test of the drugs for weight loss in cats. https://www.smithsonianmag.com/smart-news/can-glp-1s-help-fat-cats-lose-weight-the-first-clinical-trial-testing-the-drugs-for-weight-loss-in-felines-has-begun-180987833/
- Weight-loss drugs for cats? Company launches clinical trial of GLP-1 implants — ABC13 (December 2025). Reports the company plans to study dogs after cats, with no timeline. https://abc13.com/post/weight-loss-drugs-cats-company-launches-clinical-trial-glp-1-implants/18245988/
- Warning letter: Peak Performance Peptides — U.S. Food and Drug Administration (August 2026). FDA found that peptides labeled “research use only” were in fact sold as unapproved drugs for human use. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peak-performance-peptides-735127-08242026
- Warning letter: Pink Pony Peptides — U.S. Food and Drug Administration (March 2026). FDA warned that injectable products bypass some of the body’s key defenses against toxins and microorganisms. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovega-llc-dba-pink-pony-peptides-721088-03312026
- Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription — Ashraf AR et al., Journal of Medical Internet Research (2024). Semaglutide vials bought online were 7.7% to 14.4% pure against 99% claimed, all contained bacterial endotoxin, and the ordered pens never arrived. https://pmc.ncbi.nlm.nih.gov/articles/PMC11582493/
- 2019 AAHA Canine Life Stage Guidelines: Diagnostic testing for each life stage — American Animal Hospital Association. Recommends baseline bloodwork and urinalysis in young adult dogs, yearly testing in mature adults, and every 6 to 12 months in seniors. https://www.aaha.org/resources/life-stage-canine-2019/diagnostic-testing-for-each-life-stage/
- VetFinder: Find a Holistic Veterinarian — American Holistic Veterinary Medical Association. Directory of U.S. licensed veterinarians who offer integrative and holistic services. https://www.ahvma.org/find-a-holistic-veterinarian/
- Effects of diet restriction on life span and age-related changes in dogs — Kealy RD et al., Journal of the American Veterinary Medical Association (2002). In 48 paired Labradors, dogs fed 25% less lived significantly longer and developed chronic disease later. https://pubmed.ncbi.nlm.nih.gov/11991408/
- Study finds dogs fed reduced-calorie diet live nearly two years longer — Penn Today, University of Pennsylvania (2002). Reports the Labrador study’s median life spans: 13 years for lean-fed dogs versus 11.2 years for the comparison group. https://penntoday.upenn.edu/news/study-finds-dogs-fed-reduced-calorie-diet-live-nearly-two-years-longer-dogs-unrestricted-diet
About Canine Revolution Dog Training
Canine Revolution Dog Training is a veteran-owned training academy on a 20-acre campus in Dorchester, SC, serving Summerville and the greater Charleston Lowcountry. Founded in 2017 by Chad Singer, a Citadel graduate, U.S. Navy veteran, IACP Professional Member and author of The Ultimate Leash Training Manual, the academy brings police K9 experience, accountability and clear communication to everyday companion dog training.
From puppy development and private coaching to our flagship 6-week board and train program and behavior modification for serious cases, a team of 20+ training professionals builds calm, reliable dogs for families across Summerville, Mount Pleasant, Daniel Island, Charleston, West Ashley and surrounding areas. Canine Revolution was voted Best Dog Trainer in the Summerville Journal Scene Readers’ Choice Awards 2026.
Chad also hosts the Pack Talk Podcast. To learn more or book a Discovery Call, call (843) 376-6452 or visit caninerevolutiondogtraining.com.